Stifel Financial Corp Astrazeneca PLC Transaction History
Stifel Financial Corp
- $106 Billion
- Q3 2025
A detailed history of Stifel Financial Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Stifel Financial Corp holds 1,176,763 shares of AZN stock, worth $105 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
1,176,763
Previous 1,147,853
2.52%
Holding current value
$105 Million
Previous $80.2 Million
12.55%
% of portfolio
0.09%
Previous 0.08%
Shares
34 transactions
Others Institutions Holding AZN
# of Institutions
1,499Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...